# Scribe Therapeutics files for IPO in test of public appetite for earlier-stage biotechs

> **Open Intelligence Dossier** · First detected: 2026-07-04 08:07 UTC · Category: Business

## Executive Summary
Scribe Therapeutics seeks $75 million in an IPO, testing market appetite for early-stage biotech.

## Intelligence Brief
Scribe Therapeutics, an Alameda-based company specializing in gene-editing and cardiovascular disease treatments, has filed for a proposed initial public offering on the Nasdaq. The company aims to raise $75 million through the listing, with notable existing stockholders including Eli Lilly.


Coverage from Renaissance Capital, The Business Journals, and Investing.com highlights the firm's focus on cholesterol-fighting treatments and gene-editing technology. Endpoints News frames the filing as a significant test of public investor sentiment toward earlier-stage biotech companies.


Future coverage is expected to clarify the proposed share price range and the specific use of proceeds for the $75 million offering. Reports do not yet specify the ticker symbol or the timing of the IPO pricing.

## Multi-Source Evidence Table
| Source Outlet | Headline | Verification URL |
|---|---|---|
| renaissancecapital.com | SCTX IPO News - Cardiovascular diseases biotech Scribe Therapeutics files for a $75 million IPO | [Source Link](https://news.google.com/rss/articles/CBMizgFBVV95cUxQT21LYmJ6SmVzS0hXOFNhbmtiXzRWNkM4bDgwSnBxbXhVSE1pdWJZQ0RNam9nb3NsUjE5d0FmbWhqWHR2ZUJIdWVNOVpXOUVMRjhRblgxRkF5anRPUFFpcURUNHNqY2cwMWhOVzFjMjh0RmpLWWh1WmhHTlNNN2ROWG8tYVlqaHlKWjVKalo3bnhmSmFTUHc4M1l5UWZyNU1LOHBoM0p5NXdBZDE1dGdrY0RJWERtWi1kdmtUeDd1TUVyT1JNeTllY2FVRFQ3UQ?oc=5) |
| The Business Journals | Meet the gene-editing, cholesterol-fighting Alameda company looking for IPO riches | [Source Link](https://news.google.com/rss/articles/CBMirAFBVV95cUxNN3RCZGxNZHo3T3lLVC1VZl8wT1JfZU96NXhvcnVleHEweWswaEYzalZJTlZpVmxHX3ItSDQ1dG9vS251ejVMWmNZam1hZkUyMkwxSFg1V0NnMlJFRTFoMHc0VTVsaHVlTE1nMkI5MkJXRnVucUxnajJiOUhtdTc4RkFoaXk3dGJhXzZPcUd3Tks3RnczM2RvS05hUGYyQXNKR1J3YXpHOU9idDNx?oc=5) |
| Investing.com South Africa | Scribe Therapeutics files for proposed Nasdaq IPO By Investing.com | [Source Link](https://news.google.com/rss/articles/CBMisAFBVV95cUxQQU1hNUhNU3dqNXFUMm9vSzdRaFRoTF9jUUtuOUZpbVF3NTJSTHJGSHh4Y19VN1U2NHRIcVRKUElPalBPaEMzOHdSNTl3NWI4ZHdfNWkwcElCcVNrV29wZmJqcEZuamI2aWVhOFNBWHpNZkpEYzR2czNWS2FqcXJReHFjU1JibWNUcVA3TC1CZG4zUU5YcHZTNFpEa0lTaWwwLTdwZXREbzJYLUtvQ1NibA?oc=5) |
| Moomoo | Scribe Therapeutics Stockholders Include Eli Lilly | [Source Link](https://news.google.com/rss/articles/CBMilwFBVV95cUxQSzUzLVRlaW5UbF9lVUJOU1lNMG50VjBteGdIZmRRelV2MlhRWkJXdEZyVmtmNHlzcnE2bkdIRktOMGRuc1JWZ2NTTWtxMzM3RlF1Qk93X0Rhb2N3ZldseFpCTHg2QXlENEwybkVYQkVaTVQ5NDgxczg4dWZqc1d1bGI5LUlyZW9oOFBVZk85RUl4ekE1NG8w?oc=5) |
| Endpoints News | Scribe Therapeutics files for IPO in test of public appetite for earlier-stage biotechs | [Source Link](https://news.google.com/rss/articles/CBMipAFBVV95cUxORlc0RVh3NmFfSW9mbERwalZ6WHV1MkpmdW5uV0ctem5Cb3R3Rk5ESFN5UDlaMW02eC1FTEJNQk00NHpGTDVMVmRYR1hBdFJoSmtZbElEbk5sUHptZF9zaFFFR2N4UUp2c0hpb0pYbXA4LWNBUzc1b3JkRkNtQzNvaFVPd1BnT0dHZFQwSFBTZHlOc1dXSzJ6bHJFMzdpb19WZWxjRw?oc=5) |

---
*Canonical Source: https://pulse.byoviral.com/trend/2026-07-04/scribe-therapeutics-files-for-ipo-in-test-of-public-appetite-for-earlier-stage*